Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Raj Makkar Added: 12 months ago
EuroPCR 25 - Post-hoc anlysis outcomes from under-expansion of the ACURATE neo2 valve in severe aortic stenosis (AS) patients show under-expansion was associated with higher rates of death, stroke or rehospitalisation.We are joined by Dr Raj Makkar (Cedars-Sinai Heart Institute, Los Angeles, US) to discuss findings from the post-hoc analysis of the ACURATE IDE study (NCT03735667; Boston… View more
Author(s): Henryk Dreger , , Added: 7 months ago
This video series is for Interventional Cardiologists, Hospital Administrators, Structural Heart Teams and Clinical Managers.Join Prof Henryk Dreger (DHZC, Berlin, DE) and other esteemed faculty, toReview the latest economic evidence that can help you to optimise and scale your TAVI programme effectively amid growing patients' needsClearly define how high-quality care and economic gains go hand… View more
Author(s): Matthias Bossard Added: 6 months ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus… View more
Author(s): Suzanne J Baron Added: 6 months ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible… View more
Job title: MSc and co-founder of Coala Life
Philip is an international serial entrepreneur, CEO and Board Member within the medical technology and life science tech sectors. Philip co-founded Coala Life in 2015 and has led several ventures to global expansion and 2x IPOs on Nasdaq. Philip has a MSc in Industrial Economics, Management and Mechanical Engineering from the Royal Institute of Technology, and currently resides with family in… View more
Added: 9 months ago Source:  Radcliffe Cardiology
A post hoc analysis of the ACURATE IDE trial has found that underexpansion of the ACURATE neo2 transcatheter heart valve (THV) was associated with a higher rate of adverse clinical outcomes at one year.¹ The original trial failed to demonstrate non-inferiority of the ACURATE neo2 valve compared with contemporary commercial valves for the primary endpoint of all-cause mortality, stroke, or… View more